The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Chitosan/siRNA Nanoparticle–mediated TNF-α Knockdown in Peritoneal Macrophages for Anti-inflammatory Treatment in a Murine Arthritis Model
Open accessAbstract
Secretion of tumor necrosis factor-alpha (TNF-alpha) by macrophages plays a predominant role in the development and progression of rheumatoid arthritis. We demonstrate that knockdown of TNF-alpha expression in systemic macrophages by intraperitoneal (i.p.) administration of chitosan/small interfering RNA (siRNA) nanoparticles in mice downregulates systemic and local inflammation. Chitosan nanoparticles containing an unmodified anti-TNF-alpha Dicer-substrate siRNA (DsiRNA) mediated TNF-alpha knockdown (approximately 66%) in primary peritoneal macrophages in vitro. The presence of Cy3-labeled nanoparticles within peritoneal macrophages and specific TNF-alpha knockdown (approximately 44%) with TNF-alpha siRNA after i.p. injection supports our therapeutic approach. Downregulation of TNF-alpha-induced inflammatory responses arrested joint swelling in collagen-induced arthritic (CIA) mice dosed i.p. with anti-TNF-alpha DsiRNA nanoparticles. The use of 2'-O-Me-modified DsiRNA resulted in the lowest arthritic scores and correlated with reduced type I interferon (IFN) activation in macrophages in vivo compared with unmodified DsiRNA. Histological analysis of joints revealed minimal cartilage destruction and inflammatory cell infiltration in anti-TNF-alpha-treated mice. The onset of arthritis could be delayed using a prophylactic dosing regime. This work demonstrates nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages as a method to reduce both local and systemic inflammation, thereby presenting a novel strategy for arthritis treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
Williams, R. O., Feldmann, M., & Maini, R. N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9784 · Cited by 989
Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy
Kim, D.-H., Behlke, M. A., Rose, S. D., Chang, M.-S., Choi, S., & Rossi, J. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1051 · Cited by 884
Self-citationMacrophages in rheumatoid arthritis.
Kinne, R. W., Bräuer, R., Stuhlmüller, B., Palombo‐Kinne, E., & Burmester, G. R. (2000) · Arthritis Research · doi:10.1186/ar86 · Cited by 758
Elliott, M. J., Maini, R. N., Feldmann, M., Long-Fox, A., Charles, P., Bijl, J. A., & Woody, J. N. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90632-7 · Cited by 640
RNA Interference in Vitro and in Vivo Using a Novel Chitosan/siRNA Nanoparticle System
Howard, K. A., Rahbek, U. L., Liu, X., Damgaard, C. K., Glud, S. Z., Andersen, M. Ø., Hovgaard, M. B., Schmitz, A., Nyengaard, J. R., Besenbacher, F., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.04.010 · Cited by 585
Self-citationDesign of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo
Judge, A. D., Bola, G., Lee, A. C. H., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.002 · Cited by 571
Gene Silencing by Systemic Delivery of Synthetic siRNAs in Adult Mice
Sørensen, D. R., Leirdal, M., & Sioud, M. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00181-5 · Cited by 464
Marques, J. T., Devosse, T., Wang, D., Zamanian-Daryoush, M., Serbinowski, P., Hartmann, R., Fujita, T., Behlke, M. A., & Williams, B. R. (2006) · Nature Biotechnology · doi:10.1038/nbt1205 · Cited by 380
Self-citationFunctional polarity is introduced by Dicer processing of short substrate RNAs
Rose, S. D. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki732 · Cited by 312
Cationic liposome-mediated delivery of siRNAs in adult mice
Sioud, M., & Sørensen, D. R. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.057 · Cited by 286
Yoon, H. J., Moon, M. E., Park, H. S., Im, S. Y., & Kim, Y. H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.042 · Cited by 208
Khoury, M., Louis‐Plence, P., Escriou, V., Noel, D., Largeau, C., Cantos, C., Scherman, D., Jorgensen, C., & Apparailly, F. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21876 · Cited by 183
Dash, P. R., Read, M. L., Fisher, K. D., Howard, K. A., Wolfert, M., Oupicky, D., Subr, V., Strohalm, J., Ulbrich, K., & Seymour, L. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3793 · Cited by 161
Self-citationReceptor-mediated stimulatory effect of oligochitosan in macrophages.
Feng, J., Zhao, L., & Yu, Q.-Q. (2004) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2004.03.048 · Cited by 149
Ikehara, Y., Niwa, T., Biao, L., Ikehara, S. K., Ohashi, N., Kobayashi, T., Shimizu, Y., Kojima, N., & Nakanishi, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0470 · Cited by 143
Schiffelers, R. M., Xu, J., Storm, G., Woodle, M. C., & Scaria, P. V. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20975 · Cited by 141
Rational design and in vitro and in vivo delivery of Dicer substrate siRNA
Amarzguioui, M., Lundberg, P. S., Cantin, E. M., Hagstrom, J. E., Behlke, M. A., & Rossi, J. J. (2006) · Nature Protocols · doi:10.1038/nprot.2006.72 · Cited by 131
Self-citationBellingan, G. J., Xu, P., Cooksley, H., Cauldwell, H., Shock, A., Bottoms, S. E., Haslett, C., Mutsaers, S. E., & Laurent, G. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011794 · Cited by 131
Williams, R. O., Marinova-Mutafchieva, L., Feldmann, M., & Maini, R. N. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7240 · Cited by 121
Amelioration of rat adjuvant‐induced arthritis by Met‐RANTES
Shahrara, S., Proudfoot, A. E. I., Woods, J. M., Ruth, J. H., Amin, M. A., Park, C. C., Haas, C. S., Pope, R. M., Haines, G. K., Zha, Y. Y., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21033 · Cited by 115
Richards, P. J., Williams, A. S., Goodfellow, R. M., & Williams, B. (1999) · Lara D. Veeken · doi:10.1093/rheumatology/38.9.818 · Cited by 107
Interfering with disease: opportunities and roadblocks to harnessing RNA interference
Lieberman, J., Song, E., Lee, S., & Shankar, P. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00143-6 · Cited by 107
Chemical Modification Patterns Compatible with High Potency Dicer-Substrate Small Interfering RNAs
Collingwood, M. A., Rose, S. D., Huang, L., Hillier, C., Amarzguioui, M., Wiiger, M. T., Soifer, H. S., Rossi, J. J., & Behlke, M. A. (2008) · Oligonucleotides · doi:10.1089/oli.2008.0123 · Cited by 105
Self-citationMechanism of Macrophage Activation by Chitin Derivatives
Mori, T., Murakami, M., Okumura, M., KADOSAWA, T., Uede, T., & FUJINAGA, T. (2005) · Journal of Veterinary Medical Science · doi:10.1292/jvms.67.51 · Cited by 85
Lundberg, P. S., Welander, P. V., Edwards, C. K., van Rooijen, N., & Cantin, E. M. (2006) · Journal of Virology · doi:10.1128/jvi.02243-06 · Cited by 73
Yarilina, A., DiCarlo, E. F., & Ivashkiv, L. B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2204 · Cited by 69
Immunotherapy for rheumatoid arthritis
Taylor, P. C., Williams, R. O., & Maini, R. N. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00269-7 · Cited by 69
Howard, K. A. (2000) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(00)00076-3 · Cited by 63
Self-citationKirino, Y., Takeno, M., Murakami, S., Kobayashi, M., Kobayashi, H., Miura, K., Ideguchi, H., Ohno, S., Ueda, A., & Ishigatsubo, Y. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22370 · Cited by 46
Nissler, K., Pohlers, D., Hückel, M., Simon, J., Bräuer, R., & Kinne, R. W. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.013060 · Cited by 33
Moore, A. (2003) · Humana Press eBooks · doi:10.1385/1-59259-374-7:175 · Cited by 13
Cited by
Chitosan-based formulations for delivery of DNA and siRNA
Mao, S., Sun, W., & Kissel, T. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.08.004 · Cited by 968
Cationic polymers and their therapeutic potential
Samal, S. K., Dash, M., Van Vlierberghe, S., Kaplan, D. L., Chiellini, E., van Blitterswijk, C., Moroni, L., & Dubruel, P. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35094g · Cited by 714
Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity
Chanda, N., Kattumuri, V., Shukla, R., Zambre, A., Katti, K., Upendran, A., Kulkarni, R. R., Kan, P., Fent, G. M., Casteel, S. W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002143107 · Cited by 321
Efficient and targeted delivery of siRNA in vivo
Shim, M. S., & Kwon, Y. J. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07904.x · Cited by 309
Csaba, N., Köping-Höggård, M., & Alonso, M. J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.028 · Cited by 307
Metadata
- Authors
- Howard, K. A., Paludan, S. R., Behlke, M. A., Besenbacher, F., Deleuran, B., & Kjems, J.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 17
- Issue
- 1
- Pages
- 162-168
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W2063472419
- Cited by
- 299
- References
- 32
- FWCI
- 8.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.